Which has higher valuation and earnings, PNTG or BLLN?

The Pennant Group has higher revenue and earnings than Billiontoone. The Pennant Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio The Pennant Group $947.71M 1.27 $29.58M $0.85 40.68 Billiontoone $305.11M 16.24 $7.45M $0.55 195.89

Does the media refer more to PNTG or BLLN?

In the previous week, Billiontoone had 4 more articles in the media than The Pennant Group. MarketBeat recorded 6 mentions for Billiontoone and 2 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.24 beat Billiontoone's score of -0.18 indicating that The Pennant Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Billiontoone 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to RDNT or PNTG?

In the previous week, RadNet had 4 more articles in the media than The Pennant Group. MarketBeat recorded 6 mentions for RadNet and 2 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.24 beat RadNet's score of 0.04 indicating that The Pennant Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral The Pennant Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer PNTG or CELC?

In the previous week, Celcuity had 1 more articles in the media than The Pennant Group. MarketBeat recorded 3 mentions for Celcuity and 2 mentions for The Pennant Group. Celcuity's average media sentiment score of 1.74 beat The Pennant Group's score of 0.24 indicating that Celcuity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment The Pennant Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Celcuity 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor VCYT or PNTG?

In the previous week, Veracyte had 4 more articles in the media than The Pennant Group. MarketBeat recorded 6 mentions for Veracyte and 2 mentions for The Pennant Group. Veracyte's average media sentiment score of 0.62 beat The Pennant Group's score of 0.24 indicating that Veracyte is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive The Pennant Group 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

The Pennant Group (PNTG) Competitors

$34.58 +0.35 (+1.02%)

Closing price 04:00 PM Eastern

Extended Trading

$34.54 -0.04 (-0.12%)

As of 04:15 PM Eastern

Compare

PNTG vs. BLLN, SHC, RDNT, CELC, and VCYT

Should you buy The Pennant Group stock or one of its competitors? MarketBeat compares The Pennant Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with The Pennant Group include Billiontoone (BLLN), Sotera Health (SHC), RadNet (RDNT), Celcuity (CELC), and Veracyte (VCYT). These companies are all part of the "healthcare" industry.

How does The Pennant Group compare to Billiontoone?

The Pennant Group (NASDAQ:PNTG) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings.

The Pennant Group has a net margin of 2.96% compared to Billiontoone's net margin of 0.00%. The Pennant Group's return on equity of 10.07% beat Billiontoone's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.96%	10.07%	4.23%
Billiontoone	N/A	N/A	N/A

85.9% of The Pennant Group shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

The Pennant Group presently has a consensus target price of $39.00, suggesting a potential upside of 12.78%. Billiontoone has a consensus target price of $125.29, suggesting a potential upside of 16.29%. Given Billiontoone's higher possible upside, analysts clearly believe Billiontoone is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

The Pennant Group has higher revenue and earnings than Billiontoone. The Pennant Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.27	$29.58M	$0.85	40.68
Billiontoone	$305.11M	16.24	$7.45M	$0.55	195.89

In the previous week, Billiontoone had 4 more articles in the media than The Pennant Group. MarketBeat recorded 6 mentions for Billiontoone and 2 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.24 beat Billiontoone's score of -0.18 indicating that The Pennant Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Billiontoone	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

The Pennant Group beats Billiontoone on 10 of the 14 factors compared between the two stocks.

How does The Pennant Group compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and The Pennant Group (NASDAQ:PNTG) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, institutional ownership, valuation and dividends.

Sotera Health has a net margin of 9.91% compared to The Pennant Group's net margin of 2.96%. Sotera Health's return on equity of 39.73% beat The Pennant Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
The Pennant Group	2.96%	10.07%	4.23%

91.0% of Sotera Health shares are held by institutional investors. Comparatively, 85.9% of The Pennant Group shares are held by institutional investors. 15.4% of Sotera Health shares are held by company insiders. Comparatively, 6.9% of The Pennant Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Sotera Health currently has a consensus target price of $20.25, suggesting a potential upside of 21.33%. The Pennant Group has a consensus target price of $39.00, suggesting a potential upside of 12.78%. Given Sotera Health's higher possible upside, analysts clearly believe Sotera Health is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
The Pennant Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75

Sotera Health has higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.19B	4.00	$77.94M	$0.41	40.71
The Pennant Group	$947.71M	1.27	$29.58M	$0.85	40.68

In the previous week, The Pennant Group had 2 more articles in the media than Sotera Health. MarketBeat recorded 2 mentions for The Pennant Group and 0 mentions for Sotera Health. The Pennant Group's average media sentiment score of 0.24 beat Sotera Health's score of 0.00 indicating that The Pennant Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Sotera Health	Neutral
The Pennant Group	Neutral

Sotera Health has a beta of 1.79, indicating that its stock price is 79% more volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.29, indicating that its stock price is 29% more volatile than the broader market.

Summary

Sotera Health beats The Pennant Group on 12 of the 16 factors compared between the two stocks.

How does The Pennant Group compare to RadNet?

RadNet (NASDAQ:RDNT) and The Pennant Group (NASDAQ:PNTG) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, analyst recommendations, risk, institutional ownership, profitability and earnings.

In the previous week, RadNet had 4 more articles in the media than The Pennant Group. MarketBeat recorded 6 mentions for RadNet and 2 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 0.24 beat RadNet's score of 0.04 indicating that The Pennant Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
The Pennant Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

77.9% of RadNet shares are owned by institutional investors. Comparatively, 85.9% of The Pennant Group shares are owned by institutional investors. 5.6% of RadNet shares are owned by insiders. Comparatively, 6.9% of The Pennant Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

RadNet presently has a consensus target price of $87.43, indicating a potential upside of 50.32%. The Pennant Group has a consensus target price of $39.00, indicating a potential upside of 12.78%. Given RadNet's stronger consensus rating and higher probable upside, equities analysts plainly believe RadNet is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90
The Pennant Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75

The Pennant Group has a net margin of 2.96% compared to RadNet's net margin of -0.66%. The Pennant Group's return on equity of 10.07% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.66%	2.77%	0.97%
The Pennant Group	2.96%	10.07%	4.23%

The Pennant Group has lower revenue, but higher earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.14B	2.13	-$18.65M	-$0.18	N/A
The Pennant Group	$947.71M	1.27	$29.58M	$0.85	40.68

RadNet has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.29, meaning that its stock price is 29% more volatile than the broader market.

Summary

The Pennant Group beats RadNet on 9 of the 16 factors compared between the two stocks.

How does The Pennant Group compare to Celcuity?

The Pennant Group (NASDAQ:PNTG) and Celcuity (NASDAQ:CELC) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

The Pennant Group has a beta of 1.29, suggesting that its share price is 29% more volatile than the broader market. Comparatively, Celcuity has a beta of 0.1, suggesting that its share price is 90% less volatile than the broader market.

The Pennant Group currently has a consensus price target of $39.00, indicating a potential upside of 12.78%. Celcuity has a consensus price target of $152.09, indicating a potential upside of 57.80%. Given Celcuity's stronger consensus rating and higher possible upside, analysts plainly believe Celcuity is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
The Pennant Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83

In the previous week, Celcuity had 1 more articles in the media than The Pennant Group. MarketBeat recorded 3 mentions for Celcuity and 2 mentions for The Pennant Group. Celcuity's average media sentiment score of 1.74 beat The Pennant Group's score of 0.24 indicating that Celcuity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
The Pennant Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Celcuity	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

The Pennant Group has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
The Pennant Group	$947.71M	1.27	$29.58M	$0.85	40.68
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 63.3% of Celcuity shares are held by institutional investors. 6.9% of The Pennant Group shares are held by insiders. Comparatively, 13.3% of Celcuity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

The Pennant Group has a net margin of 2.96% compared to Celcuity's net margin of 0.00%. The Pennant Group's return on equity of 10.07% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
The Pennant Group	2.96%	10.07%	4.23%
Celcuity	N/A	-244.61%	-50.22%

Summary

The Pennant Group beats Celcuity on 9 of the 15 factors compared between the two stocks.

How does The Pennant Group compare to Veracyte?

Veracyte (NASDAQ:VCYT) and The Pennant Group (NASDAQ:PNTG) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

In the previous week, Veracyte had 4 more articles in the media than The Pennant Group. MarketBeat recorded 6 mentions for Veracyte and 2 mentions for The Pennant Group. Veracyte's average media sentiment score of 0.62 beat The Pennant Group's score of 0.24 indicating that Veracyte is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Veracyte	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
The Pennant Group	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Veracyte presently has a consensus price target of $47.57, indicating a potential downside of 16.19%. The Pennant Group has a consensus price target of $39.00, indicating a potential upside of 12.78%. Given The Pennant Group's stronger consensus rating and higher possible upside, analysts clearly believe The Pennant Group is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56
The Pennant Group	0 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.75

Veracyte has higher earnings, but lower revenue than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Veracyte	$517.15M	8.76	$66.35M	$1.09	52.07
The Pennant Group	$947.71M	1.27	$29.58M	$0.85	40.68

Veracyte has a net margin of 16.25% compared to The Pennant Group's net margin of 2.96%. The Pennant Group's return on equity of 10.07% beat Veracyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Veracyte	16.25%	9.07%	8.38%
The Pennant Group	2.96%	10.07%	4.23%

85.9% of The Pennant Group shares are held by institutional investors. 1.4% of Veracyte shares are held by insiders. Comparatively, 6.9% of The Pennant Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Veracyte has a beta of 1.98, indicating that its share price is 98% more volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.29, indicating that its share price is 29% more volatile than the broader market.

Summary

Veracyte beats The Pennant Group on 10 of the 17 factors compared between the two stocks.

Get The Pennant Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PNTG vs. The Competition

Export

Metric	The Pennant Group	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.20B	$5.88B	$6.56B	$12.24B
Dividend Yield	N/A	1.57%	2.69%	5.82%
P/E Ratio	40.68	37.28	25.14	23.99
Price / Sales	1.27	26.07	553.65	120.26
Price / Cash	26.24	16.98	44.82	54.51
Price / Book	3.20	3.33	10.77	6.43
Net Income	$29.58M	$218.81M	$3.56B	$337.14M
7 Day Performance	N/A	4.59%	1.36%	-0.47%
1 Month Performance	1.95%	5.25%	0.80%	0.50%
1 Year Performance	18.87%	20.15%	30.54%	27.96%

The Pennant Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PNTG The Pennant Group	3.7409 of 5 stars	$34.58 +1.0%	$39.00 +12.8%	+21.3%	$1.20B	$947.71M	40.68	9,700
BLLN Billiontoone	3.3923 of 5 stars	$99.38 -1.3%	$125.29 +26.1%	N/A	$4.63B	$305.11M	180.69	620	Gap Down
SHC Sotera Health	3.518 of 5 stars	$15.46 -3.6%	$20.29 +31.2%	+42.8%	$4.57B	$1.16B	37.71	3,000	Analyst Forecast
RDNT RadNet	3.0209 of 5 stars	$52.82 -6.5%	$87.43 +65.5%	+2.4%	$4.44B	$2.04B	N/A	11,264	Insider Trade High Trading Volume
CELC Celcuity	3.5525 of 5 stars	$88.05 +0.8%	$152.09 +72.7%	+687.9%	$4.26B	N/A	N/A	40	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PNTG) was last updated on 6/24/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The Pennant Group (PNTG) Competitors

PNTG vs. BLLN, SHC, RDNT, CELC, and VCYT

How does The Pennant Group compare to Billiontoone?

Summary

How does The Pennant Group compare to Sotera Health?

Summary

How does The Pennant Group compare to RadNet?

Summary

How does The Pennant Group compare to Celcuity?

Summary

How does The Pennant Group compare to Veracyte?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PNTG vs. The Competition

The Pennant Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

The Pennant Group (PNTG) Competitors

PNTG vs. BLLN, SHC, RDNT, CELC, and VCYT

How does The Pennant Group compare to Billiontoone?

Is PNTG or BLLN more profitable?

Do institutionals and insiders hold more shares of PNTG or BLLN?

Do analysts recommend PNTG or BLLN?

Which has higher valuation and earnings, PNTG or BLLN?

Does the media refer more to PNTG or BLLN?

Summary

How does The Pennant Group compare to Sotera Health?

Is SHC or PNTG more profitable?

Do institutionals & insiders hold more shares of SHC or PNTG?

Do analysts rate SHC or PNTG?

Which has better valuation and earnings, SHC or PNTG?

Does the media favor SHC or PNTG?

Which has more risk & volatility, SHC or PNTG?

Summary

How does The Pennant Group compare to RadNet?

Does the media refer more to RDNT or PNTG?

Do institutionals and insiders believe in RDNT or PNTG?

Do analysts prefer RDNT or PNTG?

Is RDNT or PNTG more profitable?

Which has preferable valuation and earnings, RDNT or PNTG?

Which has more volatility and risk, RDNT or PNTG?

Summary

How does The Pennant Group compare to Celcuity?

Which has more risk & volatility, PNTG or CELC?

Do analysts prefer PNTG or CELC?

Does the media prefer PNTG or CELC?

Which has higher valuation & earnings, PNTG or CELC?

Do insiders and institutionals believe in PNTG or CELC?

Is PNTG or CELC more profitable?

Summary

How does The Pennant Group compare to Veracyte?

Does the media favor VCYT or PNTG?

Do analysts recommend VCYT or PNTG?

Which has better valuation and earnings, VCYT or PNTG?

Is VCYT or PNTG more profitable?

Do insiders & institutionals hold more shares of VCYT or PNTG?

Which has more risk & volatility, VCYT or PNTG?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PNTG vs. The Competition

The Pennant Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools